CJC-1295 and Sermorelin are both Growth Hormone peptides, but they're studied for different things. In short, CJC-1295 is a growth-hormone-releasing hormone analog studied for GH support, while Sermorelin is one of the earliest GHRH analogs, historically used to assess GH function. This page compares the two side by side — what each is researched for, how mature the evidence is, and how they're typically used — so you can see where they overlap and where they differ. It's educational information only, not medical advice, and neither is a substitute for a conversation with a licensed professional.
CJC-1295 vs Sermorelin at a glance
| CJC-1295 | Sermorelin | |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| In short | A growth-hormone-releasing hormone analog studied for GH support. | One of the earliest GHRH analogs, historically used to assess GH function. |
| Researched for | Growth hormone release, Body composition, Recovery & sleep | Growth hormone support, Sleep quality, Age-related GH decline |
| Research status | Some human pharmacology studies; not an approved therapy. | Historical clinical use; well-characterized pharmacology. |
| Typically stacked with | Ipamorelin | Ipamorelin |
| Key consideration | Affects the endocrine system. Research use only in most regions. | Endocrine-active. Should only be considered under medical supervision. |
How does CJC-1295 work?
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It stimulates the pituitary to release the body's own growth hormone in a more sustained way, and is often researched together with a ghrelin-type secretagogue for a more pulsatile release pattern.
How does Sermorelin work?
Sermorelin consists of the first 29 amino acids of GHRH — the active core of the hormone. It stimulates natural growth-hormone secretion and has a long clinical history, having been used diagnostically to evaluate pituitary growth-hormone function.
CJC-1295 vs Sermorelin: how to choose
Choosing between CJC-1295 and Sermorelin really comes down to your specific goal — and it's a decision for you and a licensed professional, not something to settle from a web page. CJC-1295 is most associated with Growth hormone release and Body composition, while Sermorelin leans toward Growth hormone support and Sleep quality. Where they overlap, the practical differences are usually in mechanism and how far the research has actually progressed. Selpho provides no dosing or protocols; if you'd like a research-backed steer for your goals, the free Peptide Advisor is a good starting point.
Frequently asked questions
Both are Growth Hormone peptides. CJC-1295 is a growth-hormone-releasing hormone analog studied for GH support; Sermorelin is one of the earliest GHRH analogs, historically used to assess GH function. They're most researched for Growth hormone release, Body composition (CJC-1295) and Growth hormone support, Sleep quality (Sermorelin), respectively.
There's no universal "better" — it depends on your goal, and for most of these compounds robust head-to-head human evidence doesn't exist. The right choice is one made with a licensed professional. Selpho does not rank or prescribe; it offers educational information and a research-backed advisor.
They're in the same category, and combining research compounds is something to approach only with a licensed professional, since interactions and individual context matter. Selpho provides no dosing or protocols.
CJC-1295: Some human pharmacology studies; not an approved therapy. Sermorelin: Historical clinical use; well-characterized pharmacology.
Not sure which fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis comparison is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.